logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alessandra Bearz

centro di riferimento oncologico aviano
H指数:45
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Probe-Based Confocal Laser Endomicroscopy During Immune Checkpoint Inhibitor Therapy: A Translational Framework Linking Intestinal Barrier Function, Microbiota, and Clinical Outcomes

基于探针的共聚焦激光内窥镜在免疫检查点抑制剂治疗期间的应用：连接肠道屏障功能、微生物组和临床结局的转化研究框架

Nutrients
IF5
2026-09-210
OA
Paola Spessotto; Francesca Orbosuè; Maurizio Mongiat; Stefania Maiero; Marco Sartori; Michela Guardascione; Luisa Foltran; Arianna Fumagalli; Marco de Scordilli; Alessandra Bearz; Lucia Fratino; Silvia Bolzonello; Michele Spina; Fabio Puglisi; Vincenzo Canzonieri; Renato Cannizzaro; Riccardo Dolcetti; Elena Ongaro; Stefano Realdon
CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

CHIMERA：一项关于新辅助培美曲塞联合顺铂或卡铂和培美曲塞，随后进行手术及辅助培美曲塞治疗可切除胸膜间皮瘤的II期研究

Clinical Lung Cancer
IF3.3
2026-05-270
OAAI
Giulia Pasello; Daniela Scattolin; Eleonora Faccioli; Paolo Andrea Zucali; Giuseppe Marulli; Federica Grosso; Giovanni Luca Ceresoli; Marcello Tiseo; Alessandra Bearz; Fabiana Letizia Cecere; Luana Calabrò; Francesco Callegarin; Paola Del Bianco; Gian Luca De Salvo; Federica Pezzuto; Fiorella Calabrese; Valentina Guarneri; Andrea Dell’Amore; Federico Rea
Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial

Fulzerasib 联合西妥昔单抗用于一线 KRASG12C 突变非小细胞肺癌（KROCUS）：一项单臂、多中心、Ⅰb/Ⅱ期临床试验

The Lancet Oncology
IF0
2026-03-300
PRE
Vanesa Gregorc; Margarita Majem; Giuseppe Lo Russo; Michele Maio; Stephanie Salvagni; Vanesa Gutiérrez-Calderon; Maria Gonzalez-Cao; Sergio Sandiego Contreras; Anna Koumarianou; Alessandra Bearz; Reyes Bernabé-Caro; Santiago Viteri; Miguel Fernández de Sanmamed; Flora Zagouri; Teresa Morán Bueno; Chiara Lazzari; Sergio Martínez-Recio; Ana Giménez-Capitán; Yue Zhang; Yue Shan
Defining the role and competencies of the medical oncologist in diagnostic and therapeutic care pathways: Consensus recommendations from the Italian association of medical oncology (AIOM)

定义肿瘤科医生在诊断和治疗护理路径中的角色和能力：意大利肿瘤学协会（AIOM）的共识建议

Journal of Cancer Policy
IF2
2026-01-010
OAAI
Berardi, Rossana; Rossi, Francesca; Tarantino, Valentina; De Tursi, Michele; Dinota, Angelo; Di Pinto, Giancarlo; Bianco, Roberto; Leonardi, Francesco; Bearz, Alessandra; Fabi, Alessandra; Pastorino, Alessandro; Nole, Franco; Alessandroni, Paolo; Carrozza, Francesco; Buffoni, Lucio; Latiano, Tiziana; Farci, Daniele; Spada, Massimiliano; Bengala, Carmelo; Kinspergher, Stefania; Gunnellini, Marco; Brunello, Antonella; Tucci, Marcello; Pietrantonio, Filippo; De Giorgi, Ugo; Incorvaia, Lorena; Micallo, Giovanni; Russo, Antonio; Chiari, Rita; Lambertini, Matteo; Curigliano, Giuseppe; Cinieri, Saverio; Silvestris, Nicola; Perrone, Francesco; Di Maio, Massimo; Papa, Roberto
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Clinical Lung Cancer
IF3.3
2025-12-200
PRE
Pascale Tomasini; Oscar Juan-Vidal; Raffaele Califano; Chien-Chung Lin; Pauline Hulo; Christophe Dooms; Jian Fang; Ana Blasco; Dariusz Kowalski; Jorge Salinas; Govind Babu; Tho Lye Mun; Alessandra Bearz; Veerle Surmont; Clarissa Baldotto; Richu Sharma; Oscar Arrieta; Katarzyna Stencel; Cynthia Card; Alona Zer
THE ITALIAN MAURIS PHASE IIIB TRIAL OF ATEZOLIZUMAB PLUS CARBOPLATIN AND ETOPOSIDE FOR PATIENTS WITH NEWLY DIAGNOSED EXTENSIVE-STAGE SMALL CELL LUNG CANCER: 3-YEAR END-OF-STUDY RESULTS

意大利MAURIS 3期B研究：阿替利珠单抗联合卡铂和依托泊苷治疗新诊断广泛期小细胞肺癌的3年研究结束结果

Clinical Lung Cancer
IF3.3
2025-07-090
OAAI
Floriana Morgillo; Ester Del Signore; Emilio Bria; Filippo de Marinis; Fortunato Ciardiello; Marina Chiara Garassino; Alessio Stefani; Francesco Verderame; Alessandro Morabito; Andrea Sbrana; Giuseppe Tonini; Marina Gilli; Rossana Berardi; Paola Adriana Taveggia; Alessandra Bearz; Angelo Delmonte; Maria Rita Migliorino; Cesare Gridelli; Giovanni Maria Fadda; Manuela Iero; Andrea Ardizzoni
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)

一项关于免疫治疗时代下，临床医生对晚期非小细胞肺癌（NSCLC）及体力状态较差患者的态度与生存结局的前瞻性研究：PICASO（GOIRC-04-2020）。

LUNG CANCER
IF4.4
2025-06-010
PRE
Facchinetti, Francesco; Camerini, Andrea; Bennati, Chiara; Bordi, Paola; De Carlo, Elisa; Mazzoni, Francesca; Metro, Giulio; Bertolini, Federica; Longo, Lucia; Ricciardi, Serena; Pilotto, Sara; Giardina, Donatella; Passiglia, Francesco; Scotti, Vieri; Piacentini, Paolo; Frega, Stefano; Calabro, Luana; Guida, Annalisa; Grosso, Maria Antonietta; Longobardi, Jenny; Merlini, Alessandra; Cosso, Federica; Leonetti, Alessandro; Gariazzo, Eleonora; Guaitoli, Giorgia; Belluomini, Lorenzo; Bearz, Alessandra; Tognetto, Michele; Bria, Emilio; Cortinovis, Diego Luigi; Novello, Silvia; Di Maio, Massimo; Tiseo, Marcello
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

Spartalizumab联合铂类双重化疗加或不加canakinumab治疗PD-L1-unselected，转移性NSCLC患者

BMC CANCER
IF3.4
2024-10-241
OAAI
Santoro, Armando; Pilar, Garrido; Tan, Daniel S. W.; Zugazagoitia, Jon; Shepherd, Frances A.; Bearz, Alessandra; Barlesi, Fabrice; Kim, Tae Min; Overbeck, Tobias R.; Felip, Enriqueta; Cai, Can; Simantini, Eddy; Mcculloch, Tracey; Schaefer, Eric S.
Efficacy and safety of sunvozertinib in prior platinum treated NSCLC patients with EGFR exon 20 insertion mutations: Primary analysis from the multinational WU-KONG1B pivotal study

舒沃哲在既往接受铂类治疗的、携带EGFR外显子20插入突变的NSCLC患者中的疗效与安全性：跨国WU-KONG1B关键性研究的主要分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Doucet, L.; Greillier, L.; Planchard, D.; Mazieres, J.; Felip, E.; Bosch-Barrera, J.; Cobo Dols, M.; Ghiringhelli, F.; Bearz, A.; Paz-Ares, L. G.; Tiseo, M.; Carcereny, E.; Zalcman, G.; Di Noia, V. P.; de Castro Carpeno, J.; Parra, H. J. Soto; Corral Jaime, J.; Zheng, L.; Yang, J. C-H.; Janne, P. A.
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Amivantamab联合化疗联合或不联合lazertinib治疗奥希替尼治疗EGFR突变晚期NSCLC后疾病进展: III期MARIPOSA-2研究的主要结果

ANNALS OF ONCOLOGY
IF65.4
2024-01-01101
OA
Passaro, A.; Wang, J.; Wang, Y.; Lee, S. -H.; Melosky, B.; Shih, J. -Y.; Wang, J.; Azuma, K.; Juan-Vidal, O.; Cobo, M.; Felip, E.; Girard, N.; Cortot, A. B.; Califano, R.; Cappuzzo, F.; Owen, S.; Popat, S.; Tan, J. -l.; Salinas, J.; Tomasini, P.; Gentzler, R. D.; William, W. N.; Reckamp, K. L.; Takahashi, T.; Ganguly, S.; Kowalski, D. M.; Bearz, A.; MacKean, M.; Barala, P.; Bourla, A. B.; Girvin, A.; Greger, J.; Millington, D.; Withelder, M.; Xie, J.; Sun, T.; Shah, S.; Diorio, B.; Knoblauch, R. E.; Bauml, J. M.; Campelo, R. G.; Cho, B. C.
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
ANNALS OF ONCOLOGY
IF65.4
2022-01-0110
OAAI
Novello, S.; Torri, V; Grohe, C.; Kurz, S.; Serke, M.; Wehler, T.; Meyer, A.; Ladage, D.; Geissler, M.; Colantonio, I; Cauchi, C.; Stoelben, E.; Ceribelli, A.; Kropf-Sanchen, C.; Valmadre, G.; Borra, G.; Schena, M.; Morabito, A.; Santo, A.; Gregorc, V; Chiari, R.; Reck, M.; Schmid-Bindert, G.; Folprecht, G.; Griesinger, F.; Follador, A.; Pedrazzoli, P.; Bearz, A.; Caffo, O.; Dickgreber, N. J.; Irtelli, L.; Wiest, G.; Monica, V; Porcu, L.; Manegold, C.; Scagliotti, G., V

研究方向

暂未获取到该数据
A
Alessandro Del Conte
H 指数:24论文数:155被引数:2,555
U
Umberto Tirelli
H 指数:63论文数:898被引数:1.6万
E
Enriqueta Felip
H 指数:129论文数:1,499被引数:11.1万
M
Michele Spina
H 指数:64论文数:632被引数:1.5万
M
Massimiliano Berretta
H 指数:51论文数:528被引数:1.0万
G
Giovanni Franchin
H 指数:32论文数:199被引数:3,154
E
Emilio Minatel
H 指数:19论文数:90被引数:1,610
T
Tanja Baresic
H 指数:13论文数:39被引数:850
M
Marco Trovò
H 指数:26论文数:165被引数:3,180
J
Jerry Polesel
H 指数:68论文数:433被引数:1.5万